Increased thrombin activatable fibrinolysis inhibitor activity is associated with hypofibrinolysis in dogs with sepsis
IntroductionDisorders of coagulation are well-recognized in dogs with sepsis, but data regarding fibrinolysis disorders are limited. We aimed to characterize fibrinolysis in dogs with sepsis compared to healthy controls. We hypothesized that dogs with sepsis would be hypofibrinolytic, and that hypof...
Main Authors: | Katherine E. Sotos, Robert Goggs, Alyssa P. Stablein, Marjory B. Brooks |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2023-02-01
|
Series: | Frontiers in Veterinary Science |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fvets.2023.1104602/full |
Similar Items
-
Is there any role of thrombin activatable fibrinolysis inhibitor in the development of a hypercoagulable state in gastric cancer
by: Eser Mehmet, et al.
Published: (2012-08-01) -
High thrombin-activatable fibrinolysis inhibitor expression in thrombi from stroke patients in elevated estrogen states
by: Tamanna Agarwal, et al.
Published: (2024-03-01) -
Thrombin Activatable Fibrinolysis Inhibitor (TAFI): An Updated Narrative Review
by: Machteld Sillen, et al.
Published: (2021-04-01) -
A Case-Control Study of the Dose-Response Relationship Between Thrombin Activatable Fibrinolysis Inhibitor and Acute Myocardial Infarction
by: Mengnan Zhao, et al.
Published: (2022-02-01) -
Sepsis-Associated DIC with Decreased Levels of Antithrombin and Fibrinogen is the Target for Combination Therapy with Thrombomodulin Alfa and Antithrombin
by: Hideo Wada, et al.
Published: (2023-01-01)